SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Excel Crop Care gets SC nod for export of Endosulfan Technical

01 Oct 2011 Evaluate

Pursuant to a hearing in the writ petition relating to the pesticide Endosulfan, Excel Crop Care has received Supreme Court approval for export of the existing manufactured stock of Endosulfan Technical. The company has received an approval on September 30, 2011, subject to certain conditions.

The Pesticide Industry is currently holding stock of about 1090 MT of Endosulfan Technical, which is allowed to be exported under the said order. The next hearing in the matter is fixed for October 10, 2011 for giving further directions to the Joint Expert Committee.

The company had received Supreme Court’s an ad-interim order on May 13, 2011 in the matter of a Public Interest Litigation against the company. As per the order, the production, sale and use of Endosulfan, an important product for the company, had been banned for a temporary period of eight weeks, pending receipt of an interim report from the expert committee constituted by the Government of India.

Excel Crop Care is engaged in the manufacturing of agrochemicals. It began with three manufacturing plants; over 1200 dedicated employees; a range of market-leading brands; a distribution network of 40000 dealers; a customer base running into millions. 

Technical Endosulfan is a 7:3 mixture of stereoisomers, designated α and β. α- and β-endosulfan are conformational isomers arising from the pyramidal stereochemistry of sulfur.

Peers
Company Name CMP
UPL 590.50
PI Industries 2684.05
Bayer CropScience 4185.35
Sharda Cropchem 876.80
Sumitomo Chem. India 435.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: